Organogenesis Q2 Revenue Surpasses Forecasts at $130M
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
- Latest
- Trending
Organogenesis exceeds Q2 revenue expectations at $130.2M, driven by robust sales and strategic growth plans.
Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Novanta Inc. surpasses market expectations with a 3% revenue growth in Q2 2024. Adjusted EBITDA and operating cash flow also ...
Formation Bio secures $372M Series D led by Sanofi to enhance AI-driven drug development, focusing on workflow automation and AI ...
Artificial Intelligence in Ultrasound Imaging Market to grow from USD 889.16 million in 2023 to USD 1733.08 million by 2031 ...
China challenges U.S. tech investment restrictions, warning retaliation. U.S. aims to protect national security against potential threats from advanced tech.
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Explore OpenAI's strides toward AGI with GPT-4o and what the next model might bring—advancements in AI that could revolutionize technology ...
Oregon secures nearly $700M in federal funds for high-speed internet, aiming to connect unserved areas under the BEAD proposal in ...
"Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.